PMID: 8942464Dec 1, 1996Paper

Double-blind controlled trial of sertraline versus paroxetine in the treatment of delusional depression

The American Journal of Psychiatry
Raffaella ZanardiEnrico Smeraldi

Abstract

In this study the authors evaluated the efficacy and the tolerability of sertraline and paroxetine in the treatment of delusional depression. Under double-blind conditions, 46 hospitalized patients who met the DSM-III-R criteria for major depression with psychotic features were treated with sertraline or paroxetine for 6 weeks. The response rates were 75% and 46% for sertraline and paroxetine, respectively. The dropout rate was substantial (41%) in the paroxetine group and was attributable to side effects. Selective serotonin reuptake inhibitors administered alone are useful in the treatment of delusional depression.

Citations

Oct 13, 2001·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·A SerrettiE Smeraldi
Dec 21, 2000·Current Psychiatry Reports·B L O'NealM Trivedi
Apr 23, 2003·Biological Psychiatry·Anthony J Rothschild
Dec 6, 2005·The Psychiatric Clinics of North America·Bindu ShanmughamGeorge Alexopoulos
Sep 21, 2002·Biological Psychiatry·Joseph K BelanoffAlan F Schatzberg
May 29, 2015·Acta Psychiatrica Scandinavica·S D ØstergaardB S Meyers
Jun 10, 2015·Journal of Receptor and Signal Transduction Research·Colin G Rousseaux, Stephanie F Greene
Mar 29, 2001·The Australian and New Zealand Journal of Psychiatry·S KroppU Schneider
Jul 3, 2004·Journal of Clinical Psychopharmacology·Anthony J RothschildGary D Tollefson
Jan 7, 2003·Pharmacoepidemiology and Drug Safety·Welmoed E E MeijerHubert G M Leufkens
Aug 1, 2015·The Cochrane Database of Systematic Reviews·Jaap WijkstraWillem A Nolen
Mar 1, 2009·International Clinical Psychopharmacology·David V Sheehan, Kunitoshi Kamijima
Mar 18, 2008·Journal of Clinical Psychopharmacology·Tom K BirkenhagerJan A Bruijn
Sep 23, 2000·Journal of Clinical Psychopharmacology·J A Wheeler VegaP J Tyson
Mar 15, 2006·Psychopathology·Juan Pablo LucchelliGilles Bertschy
Aug 30, 2013·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Erik M MuellerJan Wacker
May 2, 2006·The British Journal of Psychiatry : the Journal of Mental Science·Jaap WijkstraWillem A Nolen
Jul 29, 2008·Harvard Review of Psychiatry·Hesham M Hamoda, David N Osser
Jun 13, 2009·Nordic Journal of Psychiatry·Christina M DordingDavid Mischoulon
Oct 29, 2011·European Archives of Psychiatry and Clinical Neuroscience·Thomas C BaghaiUNKNOWN Section of Pharmacopsychiatry, World Psychiatric Association
Jan 24, 2012·Expert Opinion on Pharmacotherapy·Sara Gibiino, Alessandro Serretti
Apr 4, 2014·The Cochrane Database of Systematic Reviews·Marianna PurgatoCorrado Barbui
Dec 31, 1997·Journal of Clinical Psychopharmacology·R W Pies
Apr 16, 2010·The Cochrane Database of Systematic Reviews·Andrea CiprianiCorrado Barbui
Aug 5, 2020·Expert Opinion on Therapeutic Targets·James Michael BrimsonTewin Tencomnao
Aug 1, 1998·European Psychiatry : the Journal of the Association of European Psychiatrists·R Licht, P Kassow
Jun 7, 2006·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Audrey R TyrkaLinda L Carpenter
Nov 10, 1998·Journal of Psychopharmacology·P J Goodnick, B J Goldstein
Nov 10, 1998·Journal of Psychopharmacology·J D Amsterdam
Nov 10, 1998·Journal of Psychopharmacology·P J Goodnick, B J Goldstein

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.